PROGRAMS ON DEMAND
CUA Members: Log in to access printable versions and to download the tools directly to your preferred device.
QUICK LINKS:
CUAJ August 2022: Testicular cancer survivorship: Long-term toxicity and management
Male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH)
Evaluation and medical management of kidney stones
Management of testicular germ cell cancer
[CUA Best Practice Report] Diagnosis and management of nocturia
CUAJ June 2022: A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
[CUA Guideline Section 3 Program] Prostate cancer screening and early diagnoses
CUAJ April 2022: Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context
CUAJ February 2022: Use of imaging for active surveillance in testicular cancer: Is real-world practice concordant with guidelines?
[CUA Guideline] Management of small renal masses
The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.
For comments or information, email Corporate.office@cua.org